| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Del Sole, V Chiesa, G Lucignani, A Vignoli, L Giordano, M Lecchi, M P Canevin. Exploring dopaminergic activity in ring chromosome 20 syndrome: a SPECT study. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 2019-11-20. PMID:20585311. |
we conducted a study looking for correlations between r(20) mosaicism, other clinical variables and both pre-synaptic dopamine transporter (dat) expression and post-synaptic d2 receptor density. |
2019-11-20 |
2023-08-12 |
Not clear |
| A Varrone, C Halldi. New developments of dopaminergic imaging in Parkinson's disease. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 2019-11-20. PMID:22402820. |
single photon emission tomography (spect) has played an important role as main molecular imaging modality because of the availability of imaging tools such as dopamine transporter (dat) radioligands for wide clinical use. |
2019-11-20 |
2023-08-12 |
Not clear |
| Artur F Schumacher-Schuh, Carolina Francisconi, Vivian Altmann, Thais L Monte, Sidia M Callegari-Jacques, Carlos Rm Rieder, Mara H Hut. Polymorphisms in the dopamine transporter gene are associated with visual hallucinations and levodopa equivalent dose in Brazilians with Parkinson's disease. The international journal of neuropsychopharmacology. vol 16. issue 6. 2019-11-20. PMID:23363854. |
after controlling for confounders, the dopamine transporter (dat) -839 c allele was associated with visual hallucinations (prevalence ratio 2.5, 95% confidence intervals 1.13-5.5, p = 0.02). |
2019-11-20 |
2023-08-12 |
Not clear |
| Etienne Cartier, Peter J Hamilton, Andrea N Belovich, Aparna Shekar, Nicholas G Campbell, Christine Saunders, Thorvald F Andreassen, Ulrik Gether, Jeremy Veenstra-Vanderweele, James S Sutcliffe, Paula G Ulery-Reynolds, Kevin Erreger, Heinrich J G Matthies, Aurelio Gall. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine. vol 2. issue 2. 2019-11-20. PMID:25774383. |
stx1 also regulates the function of neurotransmitter transporters, including the dopamine (da) transporter (dat). |
2019-11-20 |
2023-08-13 |
Not clear |
| Artor Niccoli Asabella, Angelo Fabio Gigante, Cristina Ferrari, Alessandra Di Palo, Domenico Rubini, Emilio Paolo Mossa, Sabino Dagostino, Roberta Pellicciari, Giovanni Defazio, Giuseppe Rubin. Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's disease. Hellenic journal of nuclear medicine. vol 18 Suppl 1. 2019-11-20. PMID:26665206. |
earlier studies showed a good correlation between striatal dopamine transporter (dat) binding, measured with [(123)i] fp-cit spet and bradykinesia. |
2019-11-20 |
2023-08-13 |
Not clear |
| Zade R Holloway, Timothy G Freels, Josiah F Comstock, Hunter G Nolen, Helen J Sable, Deranda B Leste. Comparing phasic dopamine dynamics in the striatum, nucleus accumbens, amygdala, and medial prefrontal cortex. Synapse (New York, N.Y.). 2019-11-20. PMID:30317673. |
to summarize results, the present study found that the striatum and nac had increased stimulation-evoked phasic dopamine release, faster dopamine uptake (leading to restricted dopamine diffusion), weaker autoreceptor functioning, greater supply levels of available dopamine, and increased dopaminergic responses to dat blockade compared to the amygdala and mpfc. |
2019-11-20 |
2023-08-13 |
mouse |
| Sabine Hellwig, Lars Frings, Annette Masuch, Werner Vach, Katharina Domschke, Claus Normann, Philipp T Meye. Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective Journal of neural transmission (Vienna, Austria : 1996). vol 125. issue 6. 2019-11-12. PMID:29476250. |
antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective we investigated if sleep deprivation (sd) and electroconvulsive therapy (ect) affect striatal dopamine transporter (dat) availability assessed by single-photon emission computed tomography (spect) and |
2019-11-12 |
2023-08-13 |
Not clear |
| Kyoungjune Pak, Keunyoung Kim, Myung Jun Lee, Jae Meen Lee, Bum Soo Kim, Seong-Jang Kim, In Joo Ki. Prediction of future weight change with the dopamine transporter. Brain imaging and behavior. vol 13. issue 3. 2019-11-12. PMID:29744803. |
we investigated the predictive value of dopamine transporter (dat) availability in the striatum of healthy subjects using |
2019-11-12 |
2023-08-13 |
human |
| Sandeep Sharma, Linda H Kim, Kyle A Mayr, David A Elliott, Patrick J Whela. Parallel descending dopaminergic connectivity of A13 cells to the brainstem locomotor centers. Scientific reports. vol 8. issue 1. 2019-11-05. PMID:29789702. |
we then characterized the da a13 cells and report that these cells differ from canonical da neurons since they lack the dopamine transporter (dat). |
2019-11-05 |
2023-08-13 |
Not clear |
| Sandeep Sharma, Linda H Kim, Kyle A Mayr, David A Elliott, Patrick J Whela. Parallel descending dopaminergic connectivity of A13 cells to the brainstem locomotor centers. Scientific reports. vol 8. issue 1. 2019-11-05. PMID:29789702. |
the lack of dat expression, and possibly the lack of a dopamine reuptake mechanism, points to a longer time of action compared to typical dopamine neurons. |
2019-11-05 |
2023-08-13 |
Not clear |
| Corinde E Wiers, Falk W Lohoff, Jisoo Lee, Christine Muench, Clara Freeman, Amna Zehra, Stefano Marenco, Barbara K Lipska, Pavan K Auluck, Ningping Feng, Hui Sun, David Goldman, James M Swanson, Gene-Jack Wang, Nora D Volko. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study. The European journal of neuroscience. vol 48. issue 3. 2019-11-04. PMID:30033547. |
dopamine transporters (dat) are implicated in the pathogenesis and treatment of attention-deficit hyperactivity disorder (adhd) and are upregulated by chronic treatment with methylphenidate, commonly prescribed for adhd. |
2019-11-04 |
2023-08-13 |
human |
| Amine Bahi, Jean-Luc Dreye. No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice. Psychopharmacology. vol 236. issue 4. 2019-10-28. PMID:30539268. |
no effect of sex on ethanol intake and preference after dopamine transporter (dat) knockdown in adult mice. |
2019-10-28 |
2023-08-13 |
mouse |
| Amine Bahi, Jean-Luc Dreye. No effect of sex on ethanol intake and preference after dopamine transporter (DAT) knockdown in adult mice. Psychopharmacology. vol 236. issue 4. 2019-10-28. PMID:30539268. |
dopamine levels are controlled in part by transport across the cell membrane by the dopamine transporter (dat), and recent evidence showed that a polymorphism in the gene encoding dat is associated with alcoholism. |
2019-10-28 |
2023-08-13 |
mouse |
| Raul Lopez-Arnau, Leticia Duart-Castells, Barbara Aster, Jorge Camarasa, Elena Escubedo, David Pubil. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine. Psychopharmacology. vol 236. issue 3. 2019-10-25. PMID:30284596. |
it is a powerful psychostimulant and blocker of the dopamine transporter (dat), like cocaine. |
2019-10-25 |
2023-08-13 |
rat |
| Diana L Price, Maya A Koike, Asma Khan, Wolfgang Wrasidlo, Edward Rockenstein, Eliezer Masliah, Douglas Bonhau. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease. Scientific reports. vol 8. issue 1. 2019-10-22. PMID:30385782. |
results from these studies demonstrated that npt200-11 reduced alpha-synuclein pathology in cortex, reduced associated neuroinflammation (astrogliosis), normalized striatal levels of the dopamine transporter (dat) and improved motor function. |
2019-10-22 |
2023-08-13 |
mouse |
| Ryul Kim, Joongyub Lee, Han-Joon Kim, Aryun Kim, Mihee Jang, Beomseok Jeon, Un Jung Kan. CSF β-amyloid Neurology. vol 92. issue 1. 2019-10-14. PMID:30504429. |
csf β-amyloid to determine whether csf biomarkers can be used as a predictor of freezing of gait (fog) in parkinson disease (pd) and to investigate the predictive value of clinical, dopamine transporter (dat) imaging, and csf parameters both separately and in combination. |
2019-10-14 |
2023-08-13 |
Not clear |
| Megan J Moerke, Subramaniam Ananthan, Matthew L Banks, Jose M Eltit, Kelen C Freitas, Amy R Johnson, Surendra K Saini, Tyler W E Steele, S Stevens Negu. Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142. The Journal of pharmacology and experimental therapeutics. vol 367. issue 2. 2019-10-08. PMID:30150482. |
drugs that inhibit the dopamine (da) transporter (dat) include both therapeutic agents and abused drugs. |
2019-10-08 |
2023-08-13 |
rat |
| Sarah R Mikelman, Bipasha Guptaroy, Kyle C Schmitt, Kymry T Jones, Juan Zhen, Maarten E A Reith, Margaret E Gneg. Tamoxifen Directly Interacts with the Dopamine Transporter. The Journal of pharmacology and experimental therapeutics. vol 367. issue 1. 2019-10-07. PMID:30108161. |
we investigated the effect of tamoxifen on dopamine transporter (dat)-mediated dopamine uptake, dopamine efflux, and [ |
2019-10-07 |
2023-08-13 |
Not clear |
| Ching-Lin Chu, I Hui Lee, Mei Hung Chi, Kao Chin Chen, Po See Chen, Wei Jen Yao, Nan Tsing Chiu, Yen Kuang Yan. Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results. CNS spectrums. vol 23. issue 4. 2019-10-01. PMID:28847342. |
previous studies have indicated that there is dopamine transporter (dat) dysregulation and p300 abnormality in adults with attention-deficit hyperactivity disorder (adhd); however, the correlations among the three have not been fully explored. |
2019-10-01 |
2023-08-13 |
Not clear |
| Umberto M Battisti, Ramsey Sitta, Alan Harris, Farhana Sakloth, Donna Walther, Iwona Ruchala, S Stevens Negus, Michael H Baumann, Richard A Glennon, Jose M Elti. Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior. ACS chemical neuroscience. vol 9. issue 7. 2019-09-30. PMID:29697951. |
4-methylamphetamine (4-ma) is an emerging drug of abuse that acts as a substrate at plasma membrane transporters for dopamine (dat), norepinephrine (net), and serotonin (sert), thereby causing nonexocytotic release of monoamine transmitters via reverse transport. |
2019-09-30 |
2023-08-13 |
rat |